Please check your internet connection and try again.
# Meftal spas
## Overview
Meftal spas is a combination product containing mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), and hyoscine butylbromide, an anticholinergic antispasmodic.
## Primary Indications
* Symptomatic relief of abdominal pain and cramps associated with conditions like irritable bowel syndrome (IBS) and other gastrointestinal disorders.
* Management of dysmenorrhea.
## Adult Dosing
* **Meftal spas:** Typically, 1 tablet (containing mefenamic acid 250 mg and hyoscine butylbromide 10 mg) taken orally 3 times daily.
* **Maximum Dose:** Do not exceed 4 tablets in 24 hours.
## Pediatric Dosing
* There is no established pediatric dosing for Meftal spas. The safety and efficacy in children have not been studied.
## Dose Adjustments
* **Renal Impairment:** Caution is advised in patients with renal impairment. Mefenamic acid can cause renal damage.
* **Hepatic Impairment:** Caution is advised in patients with hepatic impairment.
## Contraindications
* Hypersensitivity to mefenamic acid, hyoscine butylbromide, or any other NSAIDs.
* Active gastrointestinal bleeding or perforation.
* History of gastrointestinal bleeding or perforation related to previous NSAID use.
* Severe renal, hepatic, or cardiac impairment.
* Obstructive uropathy or gastrointestinal obstruction.
* Myasthenia gravis.
* Tachyarrhythmias.
* Glaucoma (narrow-angle).
* Prostatic hypertrophy with urinary retention.
* Third trimester of pregnancy.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain, dyspepsia, dizziness, headache, dry mouth, blurred vision, constipation, urinary retention.
* **Serious:** Gastrointestinal bleeding, ulceration, perforation; renal toxicity (including interstitial nephritis, papillary necrosis); cardiovascular thrombotic events; severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis); anaphylaxis.
## Key Drug Interactions
* **NSAIDs:** Increased risk of gastrointestinal bleeding and renal toxicity when used concurrently with other NSAIDs, including aspirin.
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **SSRIs/SNRIs:** Increased risk of gastrointestinal bleeding.
* **Diuretics and antihypertensives:** May reduce their efficacy and increase the risk of renal toxicity.
* **Anticholinergics:** Additive anticholinergic effects with other drugs possessing anticholinergic properties.
* **Metoclopramide:** May decrease the effect of hyoscine butylbromide.
## Monitoring
* **Gastrointestinal Symptoms:** Monitor for signs of bleeding or ulceration (e.g., melena, hematemesis, abdominal pain).
* **Renal Function:** Monitor renal function, especially in patients with pre-existing renal disease or those on concomitant nephrotoxic agents.
* **Hepatic Function:** Monitor hepatic function, particularly with long-term use.
* **Blood Pressure:** Monitor blood pressure, especially in patients with hypertension.
## Clinical Pearls
* Meftal spas should be taken with food or milk to minimize gastrointestinal upset.
* Due to potential for dizziness and blurred vision, caution patients regarding activities requiring mental alertness, such as driving or operating machinery.
* Limit use to the shortest duration necessary to control symptoms.
* Consider alternative therapies for long-term pain management or for patients at high risk of gastrointestinal complications.
**Disclaimer:** This information is intended for clinical use and does not replace a thorough review of the most current prescribing information and relevant literature. Always verify current drug information with official product labeling or reliable drug databases before making clinical decisions.
